Latest Articles
HLTH24: Jill Biden announces $110M ARPA-H funding award, prods industry to invest in women’s health - Fierce healthcare
HLTH24: Jill Biden announces $110M ARPA-H funding award, prods industry to invest in women’s health Fierce healthcare
Published: Oct. 23, 2024, 6 p.m.
Association reported between ART and imprinting disorders - Contemporary Obgyn
Association reported between ART and imprinting disorders Contemporary Obgyn
Published: Oct. 23, 2024, 5:39 p.m.
Aspira Women's Health Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health - The Manila Times
Aspira Women's Health Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health The Manila Times
Published: Oct. 23, 2024, 3:31 p.m.
First Report of Sacituzumab Govitecan in Population Representing Current Treatment Experience - Medpage Today
First Report of Sacituzumab Govitecan in Population Representing Current Treatment Experience Medpage Today
Published: Oct. 23, 2024, 2:47 p.m.
ASCO Reading Room | Alessandro Santin, MD, on a Promising ADC for Refractory Endometrial Cancer - Medpage Today
ASCO Reading Room | Alessandro Santin, MD, on a Promising ADC for Refractory Endometrial Cancer Medpage Today
Published: Oct. 23, 2024, 2:47 p.m.
New Stroke Guidelines Include Sex-Specific Risks - Inside Precision Medicine
New Stroke Guidelines Include Sex-Specific Risks Inside Precision Medicine
Published: Oct. 23, 2024, 2:27 p.m.
Pride of Britain's young finalists whose lives were forever changed by King Charles - MSN
Pride of Britain's young finalists whose lives were forever changed by King Charles MSN
Published: Oct. 23, 2024, 1:39 p.m.
Cardiometabolic Index Predicts Endometriosis Risk - Endocrinology Advisor
Cardiometabolic Index Predicts Endometriosis Risk Endocrinology Advisor
Published: Oct. 23, 2024, 1:29 p.m.
Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium - The Manila Times
Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium The Manila Times
Published: Oct. 23, 2024, 10:06 a.m.
Apolipoprotein-B mRNA-editing complex 3B could be a new potential therapeutic target in endometriosis - Nature.com
Apolipoprotein-B mRNA-editing complex 3B could be a new potential therapeutic target in endometriosis Nature.com
Published: Oct. 23, 2024, 4:55 a.m.
Link copied to clipboard!